Moderna News - August 19, 2026
🔴 Moderna is trading 5.5% down in after-hours trading after 176.97% regular-session surge
Moderna is trading 5.5% down at $164.77, apparently due to profit-taking after its exceptional regular-session rally. - It closed at $174.38 on August 19,...
🟢 Moderna is trading 11.26% up in after-hours trading after positive Phase 3 melanoma vaccine results
Moderna is trading at $194.02 (+11.26%) after the company and Merck reported positive Phase 3 results for their personalized mRNA melanoma vaccine. -...
Moderna's Stock Doubles on Cancer Vaccine Breakthrough — But Can a Company Burning Cash Grow Into a $50 Billion Valuation?
Shares of Moderna surged as much as 104.8% to $128.92 Wednesday after the company and partner Merck announced that their personalized mRNA cancer vaccine hit...
🟢 Moderna is trading 102.38% up today after Phase 3 melanoma trial success
Moderna is trading 102.38% up at $128.92 after its personalized mRNA cancer vaccine, developed with Merck, met the primary recurrence-free-survival endpoint in...